Onfi 20 MG tablet 100S
Ended Awarded
- Contract number
- SPE2DB25FNWJZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,691
Award facts
- Contract value 100% obligated
- $14,691.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,691.16 to AmerisourceBergen Drug Corp for the supply of Onfil 20 mg tablets in quantities of 100 units. This firm fixed-price delivery order, issued on September 10, 2025, with completion targeted for September 11, 2025, represents a pediatric pharmaceutical supply requirement fulfilled through DLA's medical supply chain. The contract was competitively awarded without set-aside designation, reflecting AmerisourceBergen Drug Corp's established capability to meet federal procurement standards. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania.
This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including support to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp maintains an extensive portfolio of brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains, positioning it as a primary supplier for DoD medical logistics requirements.
Quick answers
Who was awarded contract SPE2DB25FNWJZ?
SPE2DB25FNWJZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 10, 2025.
How much is contract SPE2DB25FNWJZ worth?
The government has obligated $14,691 on SPE2DB25FNWJZ.
Is contract SPE2DB25FNWJZ an order under another contract?
Yes. SPE2DB25FNWJZ is a delivery order under SPE2DB25D3201, an indefinite delivery contract.
Was contract SPE2DB25FNWJZ competed?
The extent of competition for SPE2DB25FNWJZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award